- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Laura I. Bushnell
Events 9 results
Webinar
September 9, 2021
14th Annual King & Spalding Medical Device Summit
Speaking Engagement
July 29, 2021
Tom Knox, Laura Bushnell, Dan Kahan to Speak at NVCA Webinar on Corporate Venture Capital
Speaking Engagement
March 24, 2021
Laura Bushnell to Speak on How Women Lead Virtual Event
Speaking Engagement
September 23, 2020
Laura Bushnell, Quyen Ta to Speak on ‘Disrupting the Clubby World of Venture Capital’ Webinar
Speaking Engagement
September 10, 2020
Tom Knox, Laura Bushnell to Speak on National Venture Capital Association Webinar
Webinar
February 27, 2020
CFIUS Reform: Impact on Foreign Investment in Pharmaceutical, Medical Device and Healthcare Companies
Conference
November 15, 2016
9th Annual King & Spalding Pharmaceutical University
Conference
April 7, 2016
West Coast Pharma & Medical Device University
Conference
September 17, 2014
2014 Medical Device Summit